Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Biomedicine & Biotechnology
|
July 1, 2011
Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development
Feras Khalil, Stephanie Läer
The AAPS Journal
|
January 9, 2014
Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug
Feras Khalil, Stephanie Läer
European Journal of Drug Metabolism and Pharmacokinetics
|
June 18, 2016
Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 13, 2016
Predicting Stereoselective Disposition of Carvedilol in Adult and Pediatric Chronic Heart Failure Patients by Incorporating Pathophysiological Changes in Organ Blood Flows-A Physiologically Based Pharmacokinetic Approach
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Clinical Pharmacokinetics
|
March 17, 2015
A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Frontiers in Pharmacology
|
March 20, 2025
Novel selective glucocorticoid receptor modulator GRM-01 demonstrates dissociation of anti-inflammatory effects from adverse effects on glucose and bone metabolism
Florian Jakob, Stephanie Hennen, Michael Gautrois, et al.
Journal of Pain Research
|
February 5, 2021
Outcomes of the Pediatric Development Plan of Tapentadol
Mariëlle Eerdekens, Tatjana Radic, Melanie Sohns, et al.
Journal of Pain Research
|
December 2, 2020
Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old
Feras Khalil, Siak Leng Choi, Estelle Watson, et al.
Journal of Pain Research
|
October 7, 2022
Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to <7 Years
Renata Jończyk, Christoph Beuter, Beata Bulawa, et al.
Clinical Pharmacology in Drug Development
|
August 15, 2019
Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults
Anne Van Hecken, Björn B Burckhardt, Feras Khalil, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Biomedicine & Biotechnology
|
July 1, 2011
Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development
Feras Khalil, Stephanie Läer
The AAPS Journal
|
January 9, 2014
Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug
Feras Khalil, Stephanie Läer
European Journal of Drug Metabolism and Pharmacokinetics
|
June 18, 2016
Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 13, 2016
Predicting Stereoselective Disposition of Carvedilol in Adult and Pediatric Chronic Heart Failure Patients by Incorporating Pathophysiological Changes in Organ Blood Flows-A Physiologically Based Pharmacokinetic Approach
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Clinical Pharmacokinetics
|
March 17, 2015
A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Frontiers in Pharmacology
|
March 20, 2025
Novel selective glucocorticoid receptor modulator GRM-01 demonstrates dissociation of anti-inflammatory effects from adverse effects on glucose and bone metabolism
Florian Jakob, Stephanie Hennen, Michael Gautrois, et al.
Journal of Pain Research
|
February 5, 2021
Outcomes of the Pediatric Development Plan of Tapentadol
Mariëlle Eerdekens, Tatjana Radic, Melanie Sohns, et al.
Journal of Pain Research
|
December 2, 2020
Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old
Feras Khalil, Siak Leng Choi, Estelle Watson, et al.
Journal of Pain Research
|
October 7, 2022
Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to <7 Years
Renata Jończyk, Christoph Beuter, Beata Bulawa, et al.
Clinical Pharmacology in Drug Development
|
August 15, 2019
Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults
Anne Van Hecken, Björn B Burckhardt, Feras Khalil, et al.
Page
of 2